Profile Details

Create Project

★★★★★

☆☆☆☆☆

★★★★★

☆☆☆☆☆

Hire Dr. Aishat M.

United States

PhD Pharmacologist | Oncology Scientific Strategist | Medical Writer | Clinical Trial & Medical Affairs Communications |

Profile Summary

I am a PhD-trained pharmacologist and oncology scientific strategist with over nine years of experience translating complex cancer research into clear, evidence-based communications for scientific, clinical, and professional audiences. My expertise spans oncology drug discovery, cancer biology, precision medicine, clinical development, and scientific publishing. I have authored 14 peer-reviewed publications with more than 300 citations and have developed educational, editorial, and scientific content covering emerging therapies, FDA approvals, clinical trial results, disease education, and treatment landscapes. I partner with Medical Affairs, Clinical Development, and scientific leadership teams to transform complex data into compelling narratives that support thought leadership, scientific education, conference communications, and stakeholder engagement. From clinical trial summaries and scientific review to educational content and competitive landscape analysis, I combine scientific rigor with clear storytelling to deliver content that is accurate, engaging, and aligned with your business objectives.

Subject Matter Expertise

• ★ Cancer Research
• ★ Cancer Biology
• ★ Medical Writing
• ☆ Genetics
• ☆ Epigenetics
• ☆ PCR
• ☆ Molecular Cloning
• ☆ Gene Expression Analysis
• ☆ Mutagenesis
• ☆ Plasmid DNA
• ☆ Cell Biology
• ☆ Cell-Based Assays
• ☆ Cell Culture
• ☆ Blotting
• ☆ Immunohistochemistry
• ☆ Oncology
• ☆ SEO Medical Writing

Services

• Writing
• Research
• Consulting

Writing Medical Writing, Technical Writing, General Proofreading & Editing

Research Scientific and Technical Research, Systematic Literature Review

Consulting Scientific and Technical Consulting

Work Experience

Scientific Strategist

Onconarrative

January 2026 - Present

Scientific Communications Manager

Binaytara

February 2025 - Present

Grant Writer

HURO AI

September 2024 - November 2024

Doctoral Research Scientist

Indiana University - Indianapolis

August 2019 - June 2024

Undergraduate Research Assistant

Albany State University

September 2015 - May 2019

Student Editor

Albany State University

September 2015 - May 2019

Education

PhD (Pharmacology)

Indiana University/Purdue University at Indianapolis - United States

August 2019 - June 2024

Bachelor of Science (Biological Science)

Albany State University

August 2015 - May 2019

BSc. Biology

Albany State University - United States

January 2015 - May 2019

Certifications

• Writing with Flair: How to Become an Exceptional Writer

  LinkedIn Learning

  January 2021 - Present

• Doctor of Philosophy

  Indiana University - Indianapolis

  August 2019 - Present

Publications

JOURNAL ARTICLE

Lakshmi Prabhu, Matthew Martin, Lan Chen, Özlem Demir, Jiamin Jin, Xiumei Huang, Aishat Motolani, Mengyao Sun, Guanglong Jiang, Harikrishna Nakshatri, et al. (2023). Inhibition of PRMT5 by market drugs as a novel cancer therapeutic avenue . Genes & Diseases.

Han Wei, Antja-Voy Hartley, Aishat Motolani, Guanglong Jiang, Ahmad Safa, Lakshmi Prabhu, Yunlong Liu, Tao Lu(2022). A complex signature network that controls the upregulation of PRMT5 in colorectal cancer . Genes & Diseases. 9. (2). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 285--287. Elsevier {BV}

PREPRINT

Anbukkarasi Muniyandi, Matthew Martin, Mengyao Sun, Kamakshi Sishtla, Nathan R Jensen, Aishat Motolani, Xiaoping Qi, Michael E Boulton, Lakshmi Prabhu, Tao Lu, et al.(2022). PRMT5 is a therapeutic target in choroidal neovascularization . Cold Spring Harbor Laboratory